Company · Brossard, Quebec, Canada
Mantra Pharma Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 204
- 156 authorized now
- Natural health products
- 96
- 63 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 199
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| COLAXOR | 02450070 | Marketed | |
| M-ALENDRONATE | 02529394 | Marketed | |
| M-AMLODIPINE | 02468018 | Marketed | |
| M-AMLODIPINE | 02468026 | Marketed | |
| M-AMLODIPINE | 02468034 | Marketed | |
| M-AMOXI CLAV | 02530694 | Marketed | |
| M-AMOXI CLAV | 02542226 | Marketed | |
| M-APIXABAN | 02529009 | Marketed | |
| M-APIXABAN | 02529017 | Marketed | |
| M-ASA 80 MG CROQUABLE | 02429950 | Marketed | |
| M-ATORVASTATIN | 02471167 | Marketed | |
| M-ATORVASTATIN | 02471175 | Marketed | |
| M-ATORVASTATIN | 02471183 | Marketed | |
| M-ATORVASTATIN | 02471191 | Marketed | |
| M-AZITHROMYCIN | 02502038 | Marketed | |
| M-BETAHISTINE | 02519682 | Marketed | |
| M-BETAHISTINE | 02519690 | Marketed | |
| M-BETAHISTINE | 02519704 | Marketed | |
| M-BILASTINE | 02548410 | Marketed | |
| M-CELECOXIB | 02495465 | Marketed | |
| M-CELECOXIB | 02495473 | Marketed | |
| M-CETIRIZINE | 02512025 | Marketed | |
| M-CINACALCET | 02481987 | Marketed | |
| M-CINACALCET | 02481995 | Marketed | |
| M-CINACALCET | 02482002 | Marketed | |
| M-CITALOPRAM | 02467836 | Marketed | |
| M-CITALOPRAM | 02467844 | Marketed | |
| M-CITALOPRAM | 02532123 | Marketed | |
| M-CLARITHROMYCIN | 02471396 | Marketed | |
| M-CLINDAMYCIN | 02479923 | Marketed | |
| M-CLINDAMYCIN | 02479931 | Marketed | |
| M-CLOPIDOGREL | 02502283 | Marketed | |
| M-DAPAGLIFLOZIN | 02535297 | Marketed | |
| M-DAPAGLIFLOZIN | 02535300 | Marketed | |
| M-DIENOGEST | 02543613 | Marketed | |
| M-DILTIAZEM CD | 02546086 | Marketed | |
| M-DILTIAZEM CD | 02546094 | Marketed | |
| M-DILTIAZEM CD | 02546108 | Marketed | |
| M-DILTIAZEM CD | 02546116 | Marketed | |
| M-DILTIAZEM T | 02546434 | Marketed | |
| M-DILTIAZEM T | 02546442 | Marketed | |
| M-DILTIAZEM T | 02546450 | Marketed | |
| M-DILTIAZEM T | 02546469 | Marketed | |
| M-DILTIAZEM T | 02546477 | Marketed | |
| M-DOCUSATE SODIUM 100 MG | 02437317 | Marketed | |
| M-DONEPEZIL | 02467453 | Marketed | |
| M-DONEPEZIL | 02467461 | Marketed | |
| M-DORZOLAMIDE-TIMOLOL | 02537796 | Marketed | |
| M-DOXYCYCLINE | 02543478 | Marketed | |
| M-DULOXETINE | 02473208 | Marketed | |
| M-DULOXETINE | 02473216 | Marketed | |
| M-ESCITALOPRAM | 02471418 | Marketed | |
| M-ESCITALOPRAM | 02471426 | Marketed | |
| M-ESOMEPRAZOLE | 02520109 | Marketed | |
| M-ESOMEPRAZOLE | 02520117 | Marketed | |
| M-ESZOPICLONE | 02551187 | Marketed | |
| M-ESZOPICLONE | 02551195 | Marketed | |
| M-ESZOPICLONE | 02551209 | Marketed | |
| M-EZETIMIBE | 02467437 | Marketed | |
| M-FEBUXOSTAT | 02549425 | Marketed | |
| M-FLUCONAZOLE-150 | 02553406 | Marketed | |
| M-FLUOXETINE | 02529432 | Marketed | |
| M-FLUOXETINE | 02529440 | Marketed | |
| M-IRBESARTAN | 02524813 | Marketed | |
| M-IRBESARTAN | 02524821 | Marketed | |
| M-IRBESARTAN | 02524848 | Marketed | |
| M-LATANOPROST | 02513285 | Marketed | |
| M-LATANOPROST-TIMOLOL | 02514516 | Marketed | |
| M-LETROZOLE | 02549972 | Marketed | |
| M-METFORMIN | 02547767 | Marketed | |
| M-METFORMIN | 02547775 | Marketed | |
| M-METFORMIN | 02548275 | Marketed | |
| M-METFORMIN XR | 02551845 | Marketed | |
| M-METFORMIN XR | 02551853 | Marketed | |
| M-METHOTREXATE | 02534916 | Marketed | |
| M-METRONIDAZOLE | 02519755 | Marketed | |
| M-MIDODRINE | 02547112 | Marketed | |
| M-MIDODRINE | 02547120 | Marketed | |
| M-MONTELUKAST | 02488183 | Marketed | |
| M-MOXIFLOXACIN | 02472791 | Marketed | |
| M-NIFEDIPINE ER | 02511649 | Marketed | |
| M-PANTOPRAZOLE | 02467372 | Marketed | |
| M-PAROXETINE | 02467402 | Marketed | |
| M-PAROXETINE | 02467410 | Marketed | |
| M-PAROXETINE | 02467429 | Marketed | |
| M-PERINDOPRIL ERBUMINE | 02482924 | Marketed | |
| M-PERINDOPRIL ERBUMINE | 02482932 | Marketed | |
| M-PERINDOPRIL ERBUMINE | 02482940 | Marketed | |
| M-PILOCARPINE | 02496119 | Marketed | |
| M-PIRFENIDONE | 02550644 | Marketed | |
| M-PIRFENIDONE | 02550652 | Marketed | |
| M-PRAVASTATIN | 02476274 | Marketed | |
| M-PRAVASTATIN | 02476282 | Marketed | |
| M-PRAVASTATIN | 02476290 | Marketed | |
| M-PREGABALIN | 02467291 | Marketed | |
| M-PREGABALIN | 02467305 | Marketed | |
| M-PREGABALIN | 02467313 | Marketed | |
| M-PREGABALIN | 02467321 | Marketed | |
| M-PREGABALIN | 02541963 | Marketed | |
| M-PROGESTERONE | 02551268 | Marketed | |
| M-RIVAROXABAN | 02551608 | Marketed | |
| M-RIVAROXABAN | 02551616 | Marketed | |
| M-RIVAROXABAN | 02551624 | Marketed | |
| M-RIVAROXABAN | 02551632 | Marketed | |
| M-RIZATRIPTAN | 02547716 | Marketed | |
| M-RIZATRIPTAN ODT | 02548801 | Marketed | |
| M-RIZATRIPTAN ODT | 02548828 | Marketed | |
| M-ROSUVASTATIN | 02496534 | Marketed | |
| M-ROSUVASTATIN | 02496542 | Marketed | |
| M-ROSUVASTATIN | 02496550 | Marketed | |
| M-ROSUVASTATIN | 02496569 | Marketed | |
| M-SERTRALINE | 02530937 | Marketed | |
| M-SERTRALINE | 02530945 | Marketed | |
| M-SERTRALINE | 02530953 | Marketed | |
| M-SILDENAFIL | 02430037 | Marketed | |
| M-SITAGLIPTIN | 02534983 | Marketed | |
| M-SITAGLIPTIN | 02534991 | Marketed | |
| M-SITAGLIPTIN | 02535009 | Marketed | |
| M-TADALAFIL | 02512114 | Marketed | |
| M-TADALAFIL | 02512122 | Marketed | |
| M-TADALAFIL | 02512130 | Marketed | |
| M-TERIFLUNOMIDE | 02523833 | Marketed | |
| M-TICAGRELOR | 02529750 | Marketed | |
| M-TICAGRELOR | 02529769 | Marketed | |
| M-TRANEXAMIC ACID | 02549395 | Marketed | |
| M-TRANYLCYPROMINE | 02542188 | Marketed | |
| M-VENLAFAXINE XR | 02471280 | Marketed | |
| M-VENLAFAXINE XR | 02471299 | Marketed | |
| M-VENLAFAXINE XR | 02471302 | Marketed | |
| M-ZOLMITRIPTAN | 02566133 | Marketed | |
| M-ZOPICLONE | 02467941 | Marketed | |
| M-ZOPICLONE | 02467968 | Marketed | |
| M-ALENDRONATE | 02529408 | Approved | |
| M-AMBRISENTAN | 02554089 | Approved | |
| M-AMBRISENTAN | 02554097 | Approved | |
| M-AZITHROMYCIN | 02502046 | Approved | |
| M-BISOPROLOL | 02562251 | Approved | |
| M-BISOPROLOL | 02562278 | Approved | |
| M-CLOPIDOGREL | 02502291 | Approved | |
| M-ESCITALOPRAM | 02566885 | Approved | |
| M-ESCITALOPRAM | 02566893 | Approved | |
| M-FINASTERIDE | 02522489 | Dormant | |
| M-MONTELUKAST | 02548917 | Approved | |
| M-MONTELUKAST | 02548925 | Approved | |
| M-PANTOPRAZOLE | 02551004 | Approved | |
| M-PREGABALIN | 02541939 | Approved | |
| M-PREGABALIN | 02541947 | Approved | |
| M-PREGABALIN | 02541955 | Approved | |
| M-RIZATRIPTAN | 02547708 | Approved | |
| M-SILDENAFIL | 02430010 | Approved | |
| M-SILDENAFIL | 02430029 | Approved | |
| M-SITAGLIPTIN-METFORMIN | 02570602 | Approved | |
| M-SITAGLIPTIN-METFORMIN | 02570610 | Approved | |
| M-SITAGLIPTIN-METFORMIN | 02570629 | Approved | |
| M-TADALAFIL | 02512106 | Approved | |
| QOSEQU | 02570750 | Approved | |
| ERTAPENEM FOR INJECTION | 02539799 | Cancelled Pre Market | |
| M-ACETAMINOPHEN 325MG | 02451018 | Cancelled Post Market | |
| M-ACETAMINOPHEN 500MG | 02451123 | Cancelled Post Market | |
| M-ALENDRONATE | 02529416 | Cancelled Pre Market | |
| M-ATORVASTATIN | 02467704 | Cancelled Pre Market | |
| M-ATORVASTATIN | 02467712 | Cancelled Pre Market | |
| M-ATORVASTATIN | 02467720 | Cancelled Pre Market | |
| M-ATORVASTATIN | 02467739 | Cancelled Pre Market | |
| M-CLARITHROMYCIN | 02471388 | Cancelled Post Market | |
| M-DARUNAVIR | 02522284 | Cancelled Post Market | |
| M-DARUNAVIR | 02522276 | Cancelled Pre Market | |
| M-DARUNAVIR | 02522292 | Cancelled Post Market | |
| M-DOCUSATE CALCIUM | 02413256 | Cancelled Pre Market | |
| M-ESCITALOPRAM | 02467380 | Cancelled Pre Market | |
| M-ESCITALOPRAM | 02467399 | Cancelled Pre Market | |
| M-LACTULOSE | 02447797 | Cancelled Pre Market | |
| M-LANSOPRAZOLE | 02489805 | Cancelled Post Market | |
| M-LANSOPRAZOLE | 02489813 | Cancelled Post Market | |
| M-LEVETIRACETAM | 02524562 | Cancelled Post Market | |
| M-LEVETIRACETAM | 02524570 | Cancelled Post Market | |
| M-LEVETIRACETAM | 02524589 | Cancelled Post Market | |
| M-MONTELUKAST | 02488167 | Cancelled Pre Market | |
| M-MONTELUKAST | 02488175 | Cancelled Pre Market | |
| M-OLMESARTAN | 02479958 | Cancelled Pre Market | |
| M-OLMESARTAN | 02479966 | Cancelled Pre Market | |
| M-PRAVASTATIN | 02467348 | Cancelled Pre Market | |
| M-PRAVASTATIN | 02467356 | Cancelled Pre Market | |
| M-PRAVASTATIN | 02467364 | Cancelled Pre Market | |
| M-QUETIAPINE FUMARATE XR | 02527928 | Cancelled Post Market | |
| M-QUETIAPINE FUMARATE XR | 02527936 | Cancelled Post Market | |
| M-QUETIAPINE FUMARATE XR | 02527944 | Cancelled Post Market | |
| M-QUETIAPINE FUMARATE XR | 02527952 | Cancelled Post Market | |
| M-QUETIAPINE FUMARATE XR | 02527960 | Cancelled Post Market | |
| M-RANITIDINE | 02473534 | Cancelled Post Market | |
| M-RANITIDINE | 02473542 | Cancelled Post Market | |
| M-ROSUVASTATIN | 02467259 | Cancelled Pre Market | |
| M-ROSUVASTATIN | 02467267 | Cancelled Pre Market | |
| M-ROSUVASTATIN | 02467275 | Cancelled Pre Market | |
| M-ROSUVASTATIN | 02467283 | Cancelled Pre Market | |
| M-SOLIFENACIN SUCCINATE | 02529696 | Cancelled Post Market | |
| M-SOLIFENACIN SUCCINATE | 02529718 | Cancelled Post Market | |
| M-VALSARTAN | 02473186 | Cancelled Pre Market | |
| M-VALSARTAN | 02473194 | Cancelled Pre Market | |
| M-VALSARTAN | 02473437 | Cancelled Pre Market | |
| M-VALSARTAN | 02524511 | Cancelled Post Market | |
| M-VALSARTAN | 02524538 | Cancelled Post Market | |
| M-VALSARTAN | 02524546 | Cancelled Post Market | |
| M-ZOPICLONE | 02482800 | Cancelled Post Market |
Natural health products
Active licences first, newest first.
| Name | NPN | Status | Licensed |
|---|---|---|---|
| M-Lactase Enzyme | 80147694 | Active | |
| M-D1000 tab | 80147178 | Active | |
| mcal D2500 | 80126493 | Active | |
| mcal D2000 | 80126340 | Active | |
| M-Sodium Bicarbonate | 80123328 | Active | |
| M-D2000 gel | 80121129 | Active | |
| CARDIOSMILE | 80118222 | Active | |
| M-Sodium Phosphate | 80112397 | Active | |
| mcal citrate D1000 powder | 80106098 | Active | |
| mcal citrate powder | 80104213 | Active | |
| Denta Gum - Tutti frutti flavour | 80093292 | Active | |
| Denta Mint-Tutti frutti flavour | 80091109 | Active | |
| BariaVit | 80089894 | Active | |
| BariaCal | 80089906 | Active | |
| BariaKit | 80089905 | Active | |
| Denta Peroxide | 80085392 | Active | |
| Denta Moist | 80083896 | Active | |
| M-D400 Drops/ Gouttes | 80082751 | Active | |
| M-Magnesium Oxide 835 mg | 80082655 | Active | |
| M-Senna 8.6 mg | 80079884 | Active | |
| M-Urea 20% | 80079151 | Active | |
| Eczederm HC 1% | 80076663 | Active | |
| ECZEDERM HC 1% PROTECTION | 80076664 | Active | |
| ECZEDERM PROTECTION | 80076402 | Active | |
| M-Magnesium Complex | 80075564 | Active | |
| M-HC 1% Urea 10% cream | 80073645 | Active | |
| M-K20 Soluble | 80071412 | Active | |
| Denta Mint | 80071303 | Active | |
| Denta Gum | 80071189 | Active | |
| M-HC 1% Lotion | 80066168 | Active | |
| M-HC 1% cream | 80066164 | Active | |
| M-HC 1% Protection cream | 80066167 | Active | |
| M-HC AC 1% | 80066165 | Active | |
| M-Magnesium Gluconate | 80062929 | Active | |
| M-Fer Polysaccharide | 80062583 | Active | |
| M-Fer Fumarate | 80061196 | Active | |
| M-Vita 3B | 80060759 | Active | |
| Denta Rinse 0.05% | 80059137 | Active | |
| Denta Rinse 0.2% | 80059140 | Active | |
| M-Fer Sulfate | 80057416 | Active | |
| M-B12 100 mcg | 80055740 | Active | |
| M-B12 1000 mcg | 80055741 | Active | |
| M-B12 250 mcg | 80055743 | Active | |
| mcal | 80055526 | Active | |
| M-D400 gel | 80055196 | Active | |
| M-D1000 gel | 80055204 | Active | |
| mcal citrate liquide | 80054756 | Active | |
| M-Sennosides | 80054498 | Active | |
| M-B1 50 mg | 80054199 | Active | |
| M-B1 100 mg | 80054205 | Active | |
| mcal D1000 à croquer | 80050701 | Active | |
| mcal® citrate D1000 liquide | 80049201 | Active | |
| M-B12 2000 mcg L.A. | 80047075 | Active | |
| M-B12 1500 mcg L.A. | 80044420 | Active | |
| M-B12 1200 mcg L.A. | 80042834 | Active | |
| M-K8 L.A. | 80035346 | Active | |
| MK 20 à libération prolongée | 80025624 | Active | |
| M-Lactase Enzyme | 80019760 | Active | |
| M-Lactase Enzyme | 80019763 | Active | |
| mcal® D1000 | 80019536 | Active | |
| mcal® D800 | 80019533 | Active | |
| mcal® D400 | 80013329 | Active | |
| mcal® D400 à croquer | 80009412 | Active | |
| Denta Gel | 80087745 | Discontinued | |
| M-HC 1% Protection | 80078400 | Discontinued | |
| M-Fer Polypeptide | 80077532 | Discontinued | |
| NauziaPrev | 80077207 | Discontinued | |
| UREDERMA 10 | 80076666 | Discontinued | |
| UREDERMA 10 Lotion | 80076668 | Discontinued | |
| ECZEDERM Protection | 80076491 | Discontinued | |
| M-Remedialyte | 80073797 | Discontinued | |
| M-HC 1% Urea 10% lotion | 80073689 | Discontinued | |
| M-Magnesium | 80072191 | Discontinued | |
| M-K10 L.A. | 80069807 | Discontinued | |
| M-Plavite | 80063438 | Discontinued | |
| M-Folique 1 mg | 80061488 | Discontinued | |
| M-Vita 3B+C | 80061286 | Discontinued | |
| M-Multi 10 | 80059492 | Discontinued | |
| M-Fer Gluconate | 80059198 | Discontinued | |
| M-Magnesium Gluconate | 80059190 | Discontinued | |
| M-Plavite | 80059195 | Discontinued | |
| M-B6 25 mg | 80056458 | Discontinued | |
| M-Vita 3B+C | 80056457 | Discontinued | |
| M-Multi 10 | 80056433 | Discontinued | |
| M-Vita 3B | 80056059 | Discontinued | |
| Mantra sennosides 8,6 mg | 80055640 | Discontinued | |
| M-Sennosides 12 mg | 80055641 | Discontinued | |
| Sennosides 12mg | 80055601 | Discontinued | |
| M-K Efferlyte | 80055255 | Discontinued | |
| M-Cal Solution D 1000 | 80054761 | Discontinued | |
| MCal Solution | 80054754 | Discontinued | |
| MCal Solution D 400 | 80054755 | Discontinued | |
| M Cl D715 | 80049370 | Discontinued | |
| M Sennosides | 80043280 | Discontinued | |
| M Cal D 500, Calcium Carbonate 500 mg + Vitamine D 500 UI | 80031136 | Discontinued | |
| M K-10 | 80026332 | Discontinued |
Notices of Compliance
Newest first.
- M-CITALOPRAMSeptember 24, 2026 · NOC 38336 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-DULOXETINESeptember 15, 2026 · NOC 38287 · Supplement to an Abbreviated New Drug Submission (SANDS)
- QOSEQUAugust 12, 2026 · NOC 38100 · New Drug Submission (NDS)
- M-RIZATRIPTANAugust 5, 2026 · NOC 38052 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-SITAGLIPTIN-METFORMINAugust 5, 2026 · NOC 38053 · Abbreviated New Drug Submission (ANDS)
- M-IRBESARTANJuly 31, 2026 · NOC 38039 · Abbreviated New Drug Submission (ANDS)
- M-AMBRISENTANJuly 24, 2026 · NOC 37972 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-ZOPICLONEJuly 22, 2026 · NOC 37950 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-TICAGRELORJuly 10, 2026 · NOC 37887 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-CELECOXIBJuly 6, 2026 · NOC 37851 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-DILTIAZEM CDJune 30, 2026 · NOC 37812 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-PROGESTERONEJune 29, 2026 · NOC 37790 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-ATORVASTATINJune 19, 2026 · NOC 37745 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-MONTELUKASTMay 20, 2026 · NOC 37583 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-FINASTERIDEMay 15, 2026 · NOC 37553 · Abbreviated New Drug Submission (ANDS)
- M-RIVAROXABANApril 23, 2026 · NOC 37386 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-BILASTINEApril 22, 2026 · NOC 37380 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-ESCITALOPRAMMarch 23, 2026 · NOC 37163 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-VENLAFAXINE XRMarch 5, 2026 · NOC 37040 · Abbreviated New Drug Submission (ANDS)
- M-ZOLMITRIPTANFebruary 25, 2026 · NOC 36974 · Abbreviated New Drug Submission (ANDS)
- M-DILTIAZEM TFebruary 24, 2026 · NOC 36968 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-DONEPEZILJanuary 20, 2026 · NOC 36752 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-DAPAGLIFLOZINDecember 30, 2025 · NOC 36652 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-METHOTREXATEDecember 10, 2025 · NOC 36507 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-APIXABANNovember 24, 2025 · NOC 36416 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-ALENDRONATENovember 18, 2025 · NOC 36394 · Abbreviated New Drug Submission (ANDS)
- M-SITAGLIPTINNovember 4, 2025 · NOC 36319 · Abbreviated New Drug Submission (ANDS)
- M-CETIRIZINEOctober 24, 2025 · NOC 36238 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-LATANOPROSTOctober 24, 2025 · NOC 36239 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-BISOPROLOLOctober 20, 2025 · NOC 36208 · Abbreviated New Drug Submission (ANDS)
- M-PREGABALINOctober 10, 2025 · NOC 36142 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-SILDENAFILOctober 6, 2025 · NOC 36117 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-ROSUVASTATINOctober 5, 2025 · NOC 36120 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-ZOPICLONEOctober 3, 2025 · NOC 36137 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-EZETIMIBESeptember 9, 2025 · NOC 35970 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-PERINDOPRIL ERBUMINEJuly 22, 2025 · NOC 35712 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-ESCITALOPRAMMay 7, 2025 · NOC 35316 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-CLINDAMYCINMarch 28, 2025 · NOC 35090 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-TICAGRELORMarch 24, 2025 · NOC 35062 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-DORZOLAMIDE-TIMOLOLFebruary 20, 2025 · NOC 34881 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-AMOXI CLAVJanuary 27, 2025 · NOC 34751 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-DILTIAZEM CDJanuary 9, 2025 · NOC 34672 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-AMBRISENTANDecember 17, 2024 · NOC 34562 · Abbreviated New Drug Submission (ANDS)
- M-FLUCONAZOLE-150December 3, 2024 · NOC 34488 · Abbreviated New Drug Submission (ANDS)
- M-LATANOPROST-TIMOLOLNovember 26, 2024 · NOC 34443 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-BILASTINEOctober 22, 2024 · NOC 34247 · Abbreviated New Drug Submission (ANDS)
- M-CITALOPRAMOctober 22, 2024 · NOC 34259 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-FLUOXETINEOctober 17, 2024 · NOC 34224 · Abbreviated New Drug Submission (ANDS)
- M-PRAVASTATINOctober 15, 2024 · NOC 34194 · Abbreviated New Drug Submission (ANDS)
- M-RIVAROXABANSeptember 19, 2024 · NOC 34047 · Abbreviated New Drug Submission (ANDS)
- M-FINASTERIDESeptember 18, 2024 · NOC 34036 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-METFORMIN XRSeptember 18, 2024 · NOC 34040 · Abbreviated New Drug Submission (ANDS)
- M-PROGESTERONESeptember 4, 2024 · NOC 33927 · Abbreviated New Drug Submission (ANDS)
- M-ESZOPICLONEAugust 23, 2024 · NOC 33869 · Abbreviated New Drug Submission (ANDS)
- M-PANTOPRAZOLEAugust 21, 2024 · NOC 33851 · Abbreviated New Drug Submission (ANDS)
- M-PIRFENIDONEAugust 9, 2024 · NOC 33787 · Abbreviated New Drug Submission (ANDS)
- M-LETROZOLEJuly 17, 2024 · NOC 33650 · Abbreviated New Drug Submission (ANDS)
- M-FEBUXOSTATJuly 5, 2024 · NOC 33570 · Abbreviated New Drug Submission (ANDS)
- M-TRANEXAMIC ACIDJuly 5, 2024 · NOC 33572 · Abbreviated New Drug Submission (ANDS)
- M-TICAGRELORJune 26, 2024 · NOC 33517 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-MONTELUKASTJune 21, 2024 · NOC 33489 · Abbreviated New Drug Submission (ANDS)
- M-RIZATRIPTAN ODTJune 20, 2024 · NOC 33473 · Abbreviated New Drug Submission (ANDS)
- M-AMOXI CLAVJune 12, 2024 · NOC 33436 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-METFORMINMay 30, 2024 · NOC 33343 · New Drug Submission (NDS)
- M-METFORMINMay 24, 2024 · NOC 33291 · Abbreviated New Drug Submission (ANDS)
- M-RIZATRIPTANMay 16, 2024 · NOC 33233 · Abbreviated New Drug Submission (ANDS)
- M-AZITHROMYCINMay 6, 2024 · NOC 33181 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-MIDODRINEApril 19, 2024 · NOC 33088 · Abbreviated New Drug Submission (ANDS)
- M-ALENDRONATEApril 18, 2024 · NOC 33072 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-DILTIAZEM TMarch 18, 2024 · NOC 32906 · Abbreviated New Drug Submission (ANDS)
- M-DILTIAZEM CDMarch 11, 2024 · NOC 32854 · Abbreviated New Drug Submission (ANDS)
- M-ATORVASTATINMarch 1, 2024 · NOC 32796 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-CETIRIZINEJanuary 15, 2024 · NOC 32526 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-LANSOPRAZOLEJanuary 11, 2024 · NOC 32511 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-TERIFLUNOMIDEJanuary 9, 2024 · NOC 32561 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-DAPAGLIFLOZINDecember 21, 2023 · NOC 32405 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-AMLODIPINEDecember 15, 2023 · NOC 32363 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-LATANOPROSTDecember 1, 2023 · NOC 32237 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-DIENOGESTDecember 1, 2023 · NOC 32243 · Abbreviated New Drug Submission (ANDS)
- M-LATANOPROST-TIMOLOLNovember 30, 2023 · NOC 32216 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-DOXYCYCLINENovember 28, 2023 · NOC 32196 · Abbreviated New Drug Submission (ANDS)
- M-ATORVASTATINNovember 8, 2023 · NOC 32050 · Abbreviated New Drug Submission (ANDS)
- M-IRBESARTANOctober 20, 2023 · NOC 31913 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-ROSUVASTATINOctober 19, 2023 · NOC 31901 · Abbreviated New Drug Submission (ANDS)
- M-TRANYLCYPROMINEOctober 11, 2023 · NOC 31815 · Abbreviated New Drug Submission (ANDS)
- M-AMOXI CLAVOctober 10, 2023 · NOC 31850 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-PREGABALINOctober 6, 2023 · NOC 31797 · Abbreviated New Drug Submission (ANDS)
- M-LEVETIRACETAMSeptember 26, 2023 · NOC 31723 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-TICAGRELORAugust 28, 2023 · NOC 31503 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-PERINDOPRIL ERBUMINEAugust 18, 2023 · NOC 31445 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-MONTELUKASTAugust 3, 2023 · NOC 31368 · Abbreviated New Drug Submission (ANDS)
- ERTAPENEM FOR INJECTIONJuly 20, 2023 · NOC 31256 · Abbreviated New Drug Submission (ANDS)
- M-PAROXETINEJuly 13, 2023 · NOC 31215 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-CELECOXIBJuly 10, 2023 · NOC 31160 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-EZETIMIBEMay 30, 2023 · NOC 30874 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-DAPAGLIFLOZINMay 16, 2023 · NOC 30750 · Abbreviated New Drug Submission (ANDS)
- M-DORZOLAMIDE-TIMOLOLMay 9, 2023 · NOC 30673 · Abbreviated New Drug Submission (ANDS)
- M-DARUNAVIRMay 4, 2023 · NOC 30631 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-ESCITALOPRAMMarch 28, 2023 · NOC 30407 · Supplement to an Abbreviated New Drug Submission (SANDS)
- M-CLOPIDOGRELMarch 9, 2023 · NOC 30308 · Supplement to an Abbreviated New Drug Submission (SANDS)
The latest 100 of 199.
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- M-Pregabalin 25mg Capsules (2019-08-21)August 21, 2019 · Drugs · Product safety · Type III
- M-Folique (2019-05-10)May 10, 2019 · Natural health products · Product safety · Type II